262 related articles for article (PubMed ID: 25300673)
1. Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome.
Chighizola CB; Gerosa M; Trespidi L; Di Giacomo A; Rossi F; Acaia B; Meroni PL
Expert Rev Clin Immunol; 2014 Nov; 10(11):1505-17. PubMed ID: 25300673
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.
Chighizola CB; Ubiali T; Meroni PL
J Immunol Res; 2015; 2015():951424. PubMed ID: 26075289
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid syndrome.
George D; Erkan D
Prog Cardiovasc Dis; 2009; 52(2):115-25. PubMed ID: 19732604
[TBL] [Abstract][Full Text] [Related]
5. [Apheresis in antiphospholipid syndrome (APS)].
De Silvestro G; Tison T; Marson P
G Ital Nefrol; 2012; 29 Suppl 54():S78-83. PubMed ID: 22388836
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
[TBL] [Abstract][Full Text] [Related]
7. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
[TBL] [Abstract][Full Text] [Related]
8. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome.
de Jesus GR; Agmon-Levin N; Andrade CA; Andreoli L; Chighizola CB; Porter TF; Salmon J; Silver RM; Tincani A; Branch DW
Autoimmun Rev; 2014 Aug; 13(8):795-813. PubMed ID: 24650941
[TBL] [Abstract][Full Text] [Related]
9. Managing antiphospholipid syndrome in pregnancy.
Schreiber K; Hunt BJ
Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
[TBL] [Abstract][Full Text] [Related]
10. Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for?
Meroni PL
J Autoimmun; 2016 Dec; 75():1-5. PubMed ID: 27496152
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS').
Rodriguez-Garcia JL; Bertolaccini ML; Cuadrado MJ; Sanna G; Ateka-Barrutia O; Khamashta MA
Ann Rheum Dis; 2012 Feb; 71(2):242-4. PubMed ID: 21953349
[TBL] [Abstract][Full Text] [Related]
12. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
[TBL] [Abstract][Full Text] [Related]
13. Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.
Kwak-Kim J; Agcaoili MS; Aleta L; Liao A; Ota K; Dambaeva S; Beaman K; Kim JW; Gilman-Sachs A
Am J Reprod Immunol; 2013 Jun; 69(6):596-607. PubMed ID: 23521391
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibody syndrome and fetal outcome.
Djelmis J; Radoncić E; Ivanisević M
Acta Med Croatica; 2001; 55(3):123-30. PubMed ID: 11852731
[TBL] [Abstract][Full Text] [Related]
15. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective.
Spinillo A; Bellingeri C; De Maggio I; Riceputi G; Pandolfi MP; Spada C; Alpini C; Montecucco C; Beneventi F
J Reprod Immunol; 2021 Jun; 145():103304. PubMed ID: 33677238
[TBL] [Abstract][Full Text] [Related]
16. The treatment of anti-phospholipid syndrome: A comprehensive clinical approach.
Chighizola CB; Andreoli L; Gerosa M; Tincani A; Ruffatti A; Meroni PL
J Autoimmun; 2018 Jun; 90():1-27. PubMed ID: 29449131
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid syndrome: characteristics and obstetrical management.
Nishiguchi T; Kobayashi T
Curr Drug Targets; 2005 Aug; 6(5):593-605. PubMed ID: 16026280
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome and pregnancy.
Satta R; Biondi G
G Ital Dermatol Venereol; 2019 Jun; 154(3):277-285. PubMed ID: 30375212
[TBL] [Abstract][Full Text] [Related]
19. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature.
Andreoli L; Chighizola CB; Banzato A; Pons-Estel GJ; Ramire de Jesus G; Erkan D
Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1869-73. PubMed ID: 23861221
[TBL] [Abstract][Full Text] [Related]
20. Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study.
Ruffatti A; Favaro M; Hoxha A; Zambon A; Marson P; Del Ross T; Calligaro A; Tonello M; Nardelli GB
J Reprod Immunol; 2016 Jun; 115():14-9. PubMed ID: 27088752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
